We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Lincoln National
LNC
$7.91B
| $60.2M | 0.13% |
874,933
-255,961
| -23% | -$16.7M |
|
152
Fortive
FTV
$19B
| $59.8M | 0.12% |
1,125,017
-152,928
| -12% | -$8.37M |
|
153
Masco
MAS
$16B
| $58.6M | 0.12% |
1,055,583
+135,703
| +15% | +$8.05M |
|
154
PNC Financial Services
PNC
$100B
| $58.2M | 0.12% |
297,380
+19,708
| +7% | +$3.72M |
|
155
Endava
DAVA
$141M
| $58.1M | 0.12% |
427,650
-75,242
| -15% | -$9.71M |
|
156
Twilio
TWLO
$29.1B
| $57.6M | 0.12% |
180,467
+77,106
| +75% | +$28.1M |
|
157
Insperity
NSP
$1.85B
| $56.7M | 0.12% |
511,970
+108,421
| +27% | +$11.1M |
|
158
Baker Hughes
BKR
$56.8B
| $56.5M | 0.12% |
2,283,388
-187,918
| -8% | -$4.19M |
|
159
A.O. Smith
AOS
$8.38B
| $56.4M | 0.12% |
924,196
-180,354
| -16% | -$12.6M |
|
160
Valero Energy
VLO
$89.8B
| $55.9M | 0.12% |
792,460
-183,970
| -19% | -$12.2M |
|
161
Kraft Heinz
KHC
$30.4B
| $55.7M | 0.12% |
1,512,300
-49,072
| -3% | -$1.85M |
|
162
Oracle
ORCL
$331B
| $55.6M | 0.12% |
638,418
-321,982
| -34% | -$28.4M |
|
163
Norfolk Southern
NSC
$78.8B
| $55.6M | 0.12% |
232,263
-28,421
| -11% | -$7.29M |
|
164
Blackstone
BX
$104B
| $54.9M | 0.11% |
472,318
+158,291
| +50% | +$18.4M |
|
165
Regeneron Pharmaceuticals
REGN
$68.8B
| $54.4M | 0.11% |
89,888
-8,190
| -8% | -$5.08M |
|
166
Workday
WDAY
$33.4B
| $54.2M | 0.11% |
217,022
+105,874
| +95% | +$26.2M |
|
167
Verisk Analytics
VRSK
$26.4B
| $53.3M | 0.11% |
266,162
+16,566
| +7% | +$3.21M |
|
168
Royal Bank of Canada
RY
$291B
| $52.5M | 0.11% |
527,487
+11,212
| +2% | +$1.14M |
|
169
Clorox
CLX
$11.6B
| $52.4M | 0.11% |
316,583
-47
| -0% | -$8.09K |
|
170
CrowdStrike
CRWD
$187B
| $51.9M | 0.11% |
844,372
+74,260
| +10% | +$4.79M |
|
171
Equinix
EQIX
$107B
| $51.3M | 0.11% |
64,951
-4,370
| -6% | -$3.63M |
|
172
FMC
FMC
$1.42B
| $51.1M | 0.11% |
558,138
-238,804
| -30% | -$23.6M |
|
|
PPL
173
PPL Corp
PPL
$27.3B
| $50.7M | 0.11% |
1,817,263
+1,702
| +0.1% | +$49.1K |
|
174
Qualcomm
QCOM
$176B
| $50.5M | 0.11% |
391,390
-33,876
| -8% | -$4.81M |
|
|
STOR
175
DELISTED
STORE Capital Corporation
STOR
| $50.5M | 0.11% |
1,575,401
+1,655
| +0.1% | +$58.6K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.